Immune escape of gliomas

Progress in Brain Research

Volumn 132, Issue , 2001, Pages 685-698

  Walker, Paul R ^a   Dietrich, Pierre Yves ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; GLIOMA; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0035783952     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(01)32110-6     Document Type: Article

References (137)

1. Abbas, A.K. and Sharpe, A.H. (1999) T-cell stimulation: An abundance of B7s. Nat. Med., 5: 1345-1346.
2. Aloisi, F., Ria, F., Penna, G. and Adorini, L. (1998) Microglia are more efficient than astrocytes in antigen processing and Th1 but not Th2 cell activation. J. Immunol., 160: 4671-4680.
3. + T cell priming and Th1/Th2 cell restimulation. Eur. J. Immunol, 29: 2705-2714.
4. Aloisi, F., Ria, F. and Adorini, L. (2000) Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes, Immunol. Today, 21: 141-147.
5. Aoki, T., Tashiro, K., Miyatake, S., Kinashi, T., Nakano, T., Oda, Y., Kikuchi, H. and Honjo, T. (1992) Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc. Natl. Acad. Sci. USA, 89: 3850-3854.
6. Arai, H., Chan, S.Y., Bishop, D.K. and Nabel, G.J. (1997a) Inhibition of the alloantibody response by CD95 ligand. Nat. Med., 3: 843-848.
7. Arai, H., Gordon, D., Nabel, E.G. and Nabel, G.J. (1997b) Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA, 94: 13862-13867.
8. Asai, A., Miyagi, Y., Hashimoto, H., Lee, S.H., Mishima, K., Sugiyama, A., Tanaka, H., Mochizuki, T., Yasuda, T. and Kuchino, Y. (1994) Modulation of tumor immunogenicity of rat glioma cells by s-myc expression: Eradication of rat gliomas in vivo. Cell Growth Differ., 5: 1153-1158.
9. Ashley, D.M., Kong, F.M., Bigner, D.D. and Hale, L.P. (1998) Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Cancer Res., 58: 302-309.
10. Banchereau, J. and Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature, 392: 245-252.
11. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G. and Janeway, C.A.J. (1993) Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med., 177: 57-68.
12. Berman, R.M., Suzuki, T., Tahara, H., Robbins, P.D., Narula, S.K. and Lotze, M.T. (1996) Systemic administration of cellular IL-10 induces an effective specific, and long-lived immune response against established tumors in mice. J. Immunol., 157: 231-238.
13. Bjorkman, P.J. (1997) MHC restriction in three dimensions: A view of T cell receptor/ligand interactions. Cell, 89: 167-170.
14. 2. J. Immunol., 143: 3222-3229.
15. Border, W.A. and Noble, N.A. (1994) Transforming growth factor beta in tissue fibrosis. New Engl. J. Med., 331: 1286-1292.
16. Bruner, J.M., Langford, L.A. and Fuller, G.N. (1993) Neuropathology, cell biology, and newer diagnostic methods. Curr. Opin. Oncol., 5: 441-449.
17. Butcher, E.C. and Picker, L.J. (1996) Lymphocyte homing and homeostasis. Science, 272: 60-66.
18. Cella, M., Sallusto, F. and Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr: Opin. Immunol., 9: 10-16.
19. Chen, J.J., Sun, Y. and Nabel, G.J. (1998) Regulation of the proinflammatory effects of Fas ligand (CD95L). Science, 282: 1714-1717.
20. Couldwell, W.T., Yong, V.W., Dore-Duffy, P., Freedman, M.S. and Antel, J.P. (1992) Production of soluble autocrine inhibitory factors by human glioma cell lines. J. Neurol. Sci., 110: 178-185.
21. Cserr, H.F. and Knopf, P.M. (1992) Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view. Immunol. Today, 13: 507-512.
22. Daubener, W., Zennati, S.S., Wernet, P., Bilzer, T., Fischer, H.G. and Hadding, U. (1992) Human glioblastoma cell line 86HG39 activates T cells in an antigen specific major histocompatibility complex class II-dependent manner. J. Neuroimmunol., 41: 21-28.
23. Davis, E.J., Foster, T.D. and Thomas, W.E. (1994) Cellular forms and functions of brain microglia. Brain Res. Bull., 34: 73-78.
24. Desbaillets, I., Tada, M., de Tribolet, N., Diserens, A.C., Hamou, M.F. and Van Meir, E.G. (1994) Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro, Int. J. Cancer, 58: 240-247.
25. De Smet, C., Lurquin, C., Van der Bruggen, P., De Plaen, E., Brasseur, F. and Boon, T. (1994) Sequence and expression pattern of the human MAGE2 gene. Immunogenetics, 39: 121-129.
26. De Smet, C., Courtois, S.J., Faraoni, I., Lurquin, C., Szikora, J.P., De Backer, O. and Boon, T. (1995) Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics, 42: 282-290.
27. Dhib-Jalbut, S., Kufta, C.V., Flerlage, M., Shimojo, N. and McFarland, H.F. (1990) Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells. J. Neuroimmunol., 29: 203-211.
28. Dietrich, P.-Y., Walker, P.R., Schnuriger, V., Saas, P., Guillard, M., Gaudin, C. and Caignard, A. (1997) T cell repertoire analysis reveals significant repertoire selection during in vitro lymphocyte culture. Int. Immunol., 9: 1073-1083.
29. Dix, A.R., Brooks, W.H., Roszman, T.L. and Morford, L.A. (1999) Immune defects observed in patients with primary malignant brain tumors. J. Neuroimmunol., 100: 216-232.
30. Eglitis, M.A. and Mezey, E. (1997) Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA, 94: 4080-4085.
31. Elliott, L.H., Brooks, W.H. and Roszman, T.L. (1987) Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas. J. Neurosurg., 67: 231-236.
32. Elliott, L.H., Brooks, W.H. and Roszman, T. (1992) Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor. J. Neurooncol., 14: 1-7.
33. Fabry, Z., Waldschmidt, M.M., Hendrickson, D., Keiner, J., Love-Homan, L., Takei, F. and Hart, M.N. (1992) Adhesion molecules on murine brain microvascular endothelial cells: Expression and regulation of ICAM-1 and Lgp 55. J. Neuroimmunol., 36: 1-11.
34. Fabry, Z., Raine, C.S. and Hart,: M.N. (1994) Nervous tissue as an immune compartment: The dialect of the immune response in the CNS. Immunol. Today, 15: 218-224.
35. Fakhrai, H., Dorigo, O., Shawler, D.L., Lin, H., Mercola, D., Black, K.L., Royston, I. and Sobol, R.E. (1996) Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc. Natl. Acad. Sci. USA, 93: 2909-2914.
36. Ferguson, T.A. and Griffith, T.S. (1997) A vision of cell death: Insights into immune privilege. Immunol. Rev., 156: 167-184.
37. Fontana, A., Kristensen, F., Dubs, R., Gemsa, D. and Weber, E. (1982) Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J. Immunol., 129: 2413-2419.
38. Fontana, A., Hengartner, H., de Tribolet, N. and Weber, E. (1984) Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J. Immunol., 132: 1837-1844.
39. + T cells compared. J. Immunol., 154: 4309-4321.
40. Ford, A.L., Foulcher, E., Lemckert, F.A. and Sedgwick, J.D. (1996) Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med., 184: 1737-1745.
41. French, L.E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Miiller, C. and Tschopp, J. (1996) Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol., 133: 335-343.
42. Fukuyama, H., Adachi, M., Suematsu, S., Miwa, K., Suda, T., Yoshida, N. and Nagata, S. (1998) Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-1pr mice. J. Immunol., 160: 3805-3811.
43. Galy, A., Travis, M., Cen, D. and Chen, B. (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity, 3: 459-473.
44. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L. and Wilson, I.A. (1996) An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science, 274: 209-219.
45. Gauthier, T., Hamou, M.F., Monod, L., Gallay, P., Carrel, S. and de Tribolet, N. (1993) Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo. Acta Neurochir., 121: 199-205.
46. Green, D.R. and Ware, C.F. (1997) Fas-ligand: Privilege and peril. Proc. Natl. Acad. Sci. USA, 94: 5986-5990.
47. Grenier, Y., Ruijs, T.C., Robitaille, Y., Olivier, A. and Antel, J.P. (1989) Immunohistochemical studies of adult human glial cells. J. Neuroimmunol., 21: 103-115.
48. Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R. and Ferguson, T.A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 270: 1189-1192.
49. Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J.-C. and Tschopp, J. (1996) Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape. Science, 274: 1363-1366.
50. Heimberger, A.B., Crotty, L.E., Archer, G.E., Friedman, A.H., Bigner, D.D. and Sampson, J.H. (1999) Bone marrow-generated dendritic cells induce antitumor immunity against gliomas. Proc. Natl. Acad. Sci. USA, 40: 252.
51. Hickey, W.F. (1999) Leukocyte traffic in the central nervous system: The participants and their roles. Semin. Immunol., 11: 125-137.
52. Hickey, W.F., Hsu, B.L. and Kimura, H. (1991) T-lymphocyte entry into the central nervous system. J. Neurosci. Res., 28: 254-260.
53. Hishii, M., Nitta, T., Ishida, H., Ebato, M., Kurosu, A., Yagita, H., Sato, K. and Okumura, K. (1995) Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery, 37: 1160-1167.
54. Houbiers, J.G., Nijman, H.W., van der Burg, S.H., Drijfhout, J.W., Kenemans, P., van de Velde, C.J., Brand, A., Momburg, F., Kast, W.M. and Melief, C.J. (1993) In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur. J. Immunol., 23: 2072-2077.
55. Huang, K., Geoffroy, J.S. Singer, M.S. and Rosen, S.D. (1991) A lymphocyte homing receptor (L-selectin) mediates the in vitro attachment of lymphocytes to myelinated tracts of the central nervous system. J. Clin. Invest., 88: 1778-1783.
56. Huang, A.Y.C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D.M. and Levitsky, H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science, 264: 961-965.
57. Huber, D., Philipp, J. and Fontana, A. (1992) Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J. Immunol., 148: 277-284.
58. + T cells in the antitumor immune response. J. Exp. Med., 188: 2357-2368.
59. Irani, D.N. and Griffin, D.E. (1996) Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J. Immunol., 156: 3850-3857.
60. Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensberger, J., Apfel, R., Dorries, R., Schlingensiepen, K.H. and Brysch, W. (1993) The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J. Neurosurg., 78: 944-951.
61. Kalams, S.A. and Walker, B.D. (1998) The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med., 188: 2199-2204.
62. Krakowski, A.M. and Owens, T. (2000) Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation. Eur. J. Immunol., 30: 1002-1009.
63. Krivit, W., Sung, J.H., Shapiro, E.G. and Lockman, L. (1995) Microglia: The effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant., 4: 385-392.
64. Kufe, D.W. (2000) Smallpox, polio and now a cancer vaccine?. Nat. Med., 6: 252-253.
65. Kuppner, M.C., Hamou, M.F. and de Tribolet, N. (1990) Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas. J. Neuroimmunol., 29: 229-238.
66. Lampson, L.A. and Hickey, W.F. (1986) Monoclonal antibody analysis of MHC expression in human brain biopsies: Tissue ranging from 'histologically normal' to that showing different levels of glial tumor involvement. J. Immunol., 136: 4054-4062.
67. Lanzavecchia, A. (1998) Immunology. Licence to kill. Nature, 393: 413-414.
68. Leach, D.R., Krummel, M.F. and Allison, J.P. (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science, 271: 1734-1736.
69. Lethe, B., Van der Bruggen, P., Brasseur, F. and Boon, T. (1997) MAGE-1 expression threshold for the lysis of melanoma cell lines by a specific cytotoxic T lymphocyte. Melanoma Res., 7(Suppl. 2): S83-S88.
70. Libermann, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M.D., Ullrich, A. and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature, 313: 144-147.
71. Lowin, B., Mattmann, C., Hahne, M. and Tschopp, J. (1996) Comparison of Fas (Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int. Immunol., 8: 57-63.
72. Massa, P.T., Ozato, K. and McFarlin, D.E. (1993) Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia, 8: 201-207.
73. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol., 12: 991-1045.
74. McHeyzer-Williams, M.G., Altman, J.D. and Davis, M.M. (1996) Tracking antigen-specific helper T cell responses. Curr. Opin. Immunol., 8: 278-284.
75. Medzhitov, R. and Janeway, C.A.J. (1997) Innate immunity: Impact on the adaptive immune response. Curr. Opin. Immunol., 9: 4-9.
76. Merlo, A., Juretic, A., Zuber, M., Filgueira, L., Luscher, U., Caetano, V., Ulrich, J., Gratzl, O., Heberer, M. and Spagnoli, G. (1993) Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns. Eur. J. Cancer, 29A: 2118-2125.
77. Miyatake, S., Kikuchi, H., Iwasaki, K., Yamashita, J., Li, Z.Y., Namba, Y. and Hanaoka, M. (1988) Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma. J. Neurosurg., 69: 751-759.
78. Miescher, S., Whiteside, T.L., Carrel, S. and Von Fliedner, V. (1986) Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: Effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J. Immunol., 136: 1899-1907.
79. Monaco, J.J. (1992) A molecular model of MHC class-Irestricted antigen processing. Immunol. Today, 13: 173-179.
80. Morford, L.A., Elliott, L.H., Carlson, S.L., Brooks, W.H. and Roszman, T.L. (1997) T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J. Immunol., 159: 4415-4425.
81. Morford, L.A., Dix, A.R., Brooks, W.H. and Roszman, T.L. (1999) Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors. J. Neurosurg., 91: 935-946.
82. Mosmann, T.R. (1994) Properties and functions of interleukin-10. Adv. Immunol., 56: 1-26.
83. Moss, P.A., Rowland-Jones, S.L., Frodsham, P.M., McAdam, S., Giangrande, P., McMichael, A.J. and Bell, J.I. (1995) Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA, 92: 5773-5777.
84. Mule, J.J. (2000) Dendritic cells: At the clinical crossroads. J. Clin. Invest., 105: 707-708.
85. Münz, C., Naumann, U., Grimmel, C., Rammensee, H.G. and Weller, M. (1999) TGF-β-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells. Eur. J. Immunol., 29: 1032-1040.
86. Nitta, T., Hishii, M., Sato, K. and Okumura, K. (1994) Selective expression of interleukin-10 gene within glioblastoma multiforme. Brain Res., 649: 122-128.
87. + T cells. Proc. Natl. Acad. Sci. USA, 91: 3171-3175.
88. O'Connell, J., O'Sullivan, G.C., Collins, J.K. and Shanahan, F. (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med., 184: 1075-1082.
89. Okada, H., Tahara, H., Shurin, M.R., Attanucci, J., Giezeman-Smits, K.M., Fellows, W.K., Lotze, M.T., Chambers, W.H. and Bozik, M.E. (1998) Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective antitumor immunity against intracranial neoplasms. Int. J. Cancer, 78: 196-201.
90. Pannetier, C., Even, J. and Kourilsky, P. (1995) T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today, 16: 176-181.
91. Pardoll, D.M. (1995) Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol., 13: 399-415.
92. Pardridge, W.M., Yang, J., Buciak, J. and Tourtellotte, W.W. (1989) Human brain microvascular DR-antigen. J. Neurosci. Res., 23: 337-341.
93. Perrin, G., Schnuriger, V., Quiquerez, A.-L., Saas, P., Pannetier, C., de Tribolet, N., Tiercy, J.M., Aubry, J.P., Dietrich, P.-Y. and Walker, P.R. (1999) Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. Int. Immunol., 11: 1337-1349.
94. Pieters, J. (1997) MHC class II restricted antigen presentation. Curr. Opin. Immunol., 9: 89-96.
95. Qing, Z., Sewell, D., Sandor, M. and Fabry, Z. (2000) Antigenspecific T cell trafficking into the central nervous system. J. Neuroimmunol., 105: 169-178.
96. Reid, S.D. (2000) The control of T cell responses by dendritic cell subsets. Curr. Opin. Immunol., 12: 114-121.
97. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R. and Rubin, R. (1994) Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res., 54: 2218-2222.
98. Restifo, N.P. (2000) Not so fas: Re-evaluating the mechanisms of immune privilege and tumor escape. Nat. Med., 6: 493-495.
99. Rimoldi, D., Romero, P. and Carrel, S. (1993) The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int. J. Cancer, 54: 527-528.
100. Rock, K.L. and Goldberg, A.L. (1999) Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol., 17: 739-779.
101. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. and Schuler, G. (1994) Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180: 83-93.
102. Rosenberg, S.A. (1999) A new Era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity, 10: 281-287.
103. Rudensky, A.Y., Preston-Hurlburt, P., Hong, S.C., Barlow, A. and Janeway, C.A.J. (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature, 353: 622-627.
104. Saas, P., Walker, P.R., Hahne, M., Quiquerez, A.-L., Schnuriger, V., Perrin, G., French, L., Van Meir, E.G., de Tribolet, N., Tschopp, J. and Dietrich, P.Y. (1997) Fas Ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?. J. Clin. Invest., 99: 1173-1178.
105. Sahin, U., Tureci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I. and Pfreundschuh, M. (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA, 92: 11810-11813.
106. Satoh, J., Lee, Y.B. and Kim, S.U. (1995) T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res., 704: 92-96.
107. Sawamura, Y., Hosokawa, M., Kuppner, M.C., Kobayashi, H., Aida, T., Abe, H. and de Tribolet, N. (1989) Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitro expansion in the presence of interleukin 2. Cancer Res., 49: 1843-1849.
108. Sawamura, Y., Diserens, A.C. and de Tribolet, N. (1990) In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes. J. Neurooncol., 9: 125-130.
109. Scarcella, D.L., Chow, C.W., Gonzales, M.F., Economou, C., Brasseur, F. and Ashley, D.M. (1999) Expression of MAGE and GAGE in high-grade brain tumors: A potential target for specific immunotherapy and diagnostic markers. Clin. Cancer Res., 5: 335-341.
110. Schneider, J., Hofman, F.M., Apuzzo, M.L. and Hinton, D.R. (1992) Cytokines and immunoregulatory molecules in malignant glial neoplasms. J. Neurosurg., 77: 265-273.
111. Seino, K., Kayagaki, N., Okumura, K. and Yagita, H. (1997) Antitumor effect of locally produced CD95 ligand. Nat. Med., 3: 165-170.
112. Slavik, J.M., Hutchcroft, J.E. and Bierer, B.E. (1999) CD28/CTLA-4 and CD80/CD86 families: Signaling and function. Immunol. Res., 19: 1-24.
113. Soos, J.M., Morrow, J., Ashley, T.A., Szente, B.E., Bikoff, E.K. and Zamvil, S.S. (1998) Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J. Immunol., 161: 5959-5966.
114. Springer, T.A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell, 76: 301-314.
115. Stander, M., Naumann, U., Dumitrescu, L., Heneka, M., Loschmann, P., Gulbins, E., Dichgans, J. and Weller, M. (1998) Decorin gene transfer-mediated suppression of TGF-β synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther., 5: 1187-1194.
116. Steinman, R.M., Turley, S., Mellman, I. and Inaba, K. (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med., 191: 411-416.
117. Strand, S., Hofmann, W.J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W., Krammer, P.H. and Galle, P.R. (1996) Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?. Nat. Med., 2: 1361-1366.
118. Streilein, J.W. (1995) Unraveling immune privilege. Science, 270: 1158-1159.
119. Streilein, J.W., Taylor, A.W., Kosiewicz, M. and Takeuchi, M. (1996). In: J. Banchereau, B. Dodet, R. Schwartz and E. Trannoy (Eds.), Immune Tolerance. Elsevier, Paris, pp. 35-45.
120. Tada, M., Diserens, A.C., Desbaillets, I., Jaufeerally, R., Hamou, M.F. and de Tribolet, N. (1994) Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivo. J. Neuroimmunol., 50: 187-194.
121. Tada, M., Diserens, A.C., Hamou, M.F., Jaufeerally, R., Van Meir, E. and de Tribolet, N. (1996) Suppressed expression of T-cell costimulatory molecules B7 and B70 in human glioblastomas in vivo. In: M. Nagai (Ed.), Brain Tumor Research and Therapy. Springer Verlag, Tokyo, pp. 327-337.
122. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H. and Nagata, S. (1996) Fas ligand in human serum. Nat. Med., 2: 317-322.
123. Trojan, J., Johnson, T.R., Rudin, S.D., Ilan, J. and Tykocinski, M.L. (1993) Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science, 259: 94-97.
124. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A. and Boon, T. (1991) A gene encoding an antigen recognized by cytolyfic T lymphocytes on a human melanoma. Science, 254: 1643-1647.
125. Van Meir, E.G. (1995) Cytokines and tumors of the central nervous system. Glia, 15: 264-288.
126. Vogel, H., Butcher, E.C. and Picker, L.J. (1992) H-CAM expression in the human nervous system: Evidence for a role in diverse glial interactions. J. Neurocytol., 21: 363-373.
127. Walker, P.R., Saas, P. and Dietrich, P.-Y. (1997) The role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J. Immunol., 158: 4521-4524.
128. Walker, P.R., Saas, P. and Dietrich, P.Y. (1998) Tumor expression of Fas ligand (CD95L) and the consequences. Curr. Opin. Immunol., 10: 564-572.
129. Ward, E.S. and Qadri, A. (1997) Biophysical and structural studies of TCRs and ligands: Implications for T cell signaling. Curr. Opin. Immunol., 9: 97-106.
130. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. and Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356: 314-317.
131. Weber, F., Meinl, E., Aloisi, F., Nevinny-Stickel, C., Albert, E., Wekerle, H. and Hohlfeld, R. (1994) Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Brain, 117: 59-69.
132. Weiss, J.M., Downie, S.A., Lyman, W.D. and Berman, J.W. (1999) Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol., 161: 6893-6903.
133. Wekerle, H., Linington, C., Lassmann, H. and Meyermann, R. (1986) Cellular immune reactivity within the CNS. Trends. Neurosci., 9: 271-277.
134. Williams, K., Bar-Or, A., Ulvestad, E., Olivier, A., Antel, J.P. and Yong, V.W. (1992) Biology of adult human microglia in culture: Comparisons with peripheral blood monocytes and astrocytes. J. Neuropathol. Exp. Neurol., 51: 538-549.
135. Williams, K., Ulvestad, E. and Antel, J.P. (1994) B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol., 24: 3031-3037.
136. Wucherpfennig, K.W. (1994) Autoimmunity in the central nervous system: Mechanisms of antigen presentation and recognition. Clin. Immunol. Immunopathol., 72: 293-306.
137. Zitvogel, L., Mayordomo, J.I., Tjandrawan, T., De Leo, A.B., Clarke, M.R., Lotze, M.T. and Storkus, W.J. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med., 183: 87-97.